SCHEMBL26416286

SCHEMBL26416286

c1cc(-c2ccc3ccccc3c2)cc(-n2c3ccc(-c4ccc5[nH]c6ccccc6c5c4)cc3c3c4ccccc4ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.39
CCND1 P24385 4/20 0.39
HTR2B P41595 1/20 0.38
HTR5A P47898 1/20 0.38
PDE9A O76083 1/20 0.37
TLR9 Q9NR96 4/20 0.34
TLR8 Q9NR97 4/20 0.34
TLR7 Q9NYK1 4/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
AHR P35869 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
KIF11 P52732 1/20 0.33
ALK Q9UM73 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26048413 0.90 HTR2B (0.40) CDK4CCND1HTR2BHTR5APDE9A
SCHEMBL16836872 0.90 CDK4 (0.42) CDK4CCND1KDM4EALDH1A1HSD17B10
SCHEMBL25060045 0.85 CDK4 (0.39) CDK4CCND1HTR2BHTR5AKDM4E
SCHEMBL24766080 0.84 CDK4 (0.39) CDK4CCND1HTR2BHTR5ATLR9
SCHEMBL19045037 0.83 KDM4E (0.40) CDK4CCND1HTR2BHTR5AKDM4E
SCHEMBL21414665 0.83 CDK4 (0.38) CDK4CCND1HTR2BHTR5APDE9A
SCHEMBL31624124 0.82 CDK4 (0.51) CDK4CCND1KDM4EALDH1A1HSD17B10
SCHEMBL14979526 0.82 CDK4 (0.51) CDK4CCND1KDM4EALDH1A1HSD17B10
SCHEMBL263172 0.82 HTR2B (0.46) CDK4CCND1HTR2BHTR5APDE9A
SCHEMBL17642239 0.82 CDK4 (0.44) CDK4CCND1HTR2BHTR5APDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 CDK4 372/4885CCND1 137/4885HTR2B 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.